{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:45:27Z","timestamp":1791596727697,"version":"4.3.4"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00702-025-03088-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:00:23Z","timestamp":1766386823000},"page":"1087-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuropathology in genetic Parkinson\u2019s disease: a focused review of pathological and clinical findings"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-1563","authenticated-orcid":false,"given":"Pedro Melo","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacy Bezerra","family":"Parmera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3088_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20:1255\u20131263. https:\/\/doi.org\/10.1002\/mds.20527","journal-title":"Mov Disord"},{"key":"3088_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13395","author":"CH Adler","year":"2017","unstructured":"Adler CH, Beach TG, Shill HA et al (2017) GBA mutations in Parkinson disease: earlier death but similar neuropathological features. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.13395","journal-title":"Eur J Neurol"},{"key":"3088_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.11.006","author":"J Agin-Liebes","year":"2020","unstructured":"Agin-Liebes J, Cortes E, Vonsattel JP et al (2020) <article-title update=\"added\">Movement disorders rounds: a case of missing pathology in a patient with LRRK2 Parkinson\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.006","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.11.007","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Pletnikova O, Geiger JT et al (2019) Genetic analysis of neurodegenerative diseases in a pathology cohort. Neurobiol Aging. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.007","journal-title":"Neurobiol Aging"},{"key":"3088_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19:170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"key":"3088_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.06.017","author":"SA Bukhari","year":"2022","unstructured":"Bukhari SA, Nudelman KNH, Rumbaugh M et al (2022) <article-title update=\"added\">Parkinson\u2019s progression markers initiative brain autopsy program. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.017","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/mds.29683","volume":"39","author":"F Cardoso","year":"2024","unstructured":"Cardoso F, Goetz CG, Mestre TA et al (2024) A statement of the MDS on biological definition, staging, and classification of Parkinson\u2019s disease. Mov Disord 39:259\u2013266. https:\/\/doi.org\/10.1002\/mds.29683","journal-title":"Mov Disord"},{"key":"3088_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","volume":"147","author":"Y Chu","year":"2024","unstructured":"Chu Y, Hirst WD, Federoff HJ et al (2024) Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease. Brain 147:444\u2013457. https:\/\/doi.org\/10.1093\/brain\/awad388","journal-title":"Brain"},{"key":"3088_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.54","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Gilbert RW et al (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol. https:\/\/doi.org\/10.1001\/archneurol.2009.54","journal-title":"Arch Neurol"},{"key":"3088_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fpsyt.2016.00089","volume":"7","author":"LM Collins","year":"2016","unstructured":"Collins LM, Williams-Gray CH (2016) The genetic basis of cognitive impairment and dementia in Parkinson\u2019s disease. Front Psychiatry 7:89","journal-title":"Front Psychiatry"},{"key":"3088_CR11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505. https:\/\/doi.org\/10.1093\/brain\/awr031","journal-title":"Brain"},{"key":"3088_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.01.005","author":"MR Cornejo-Olivas","year":"2015","unstructured":"Cornejo-Olivas MR, Torres L, Mata IF et al (2015) <article-title update=\"added\">A Peruvian family with a novel PARK2 mutation: clinical and\u00a0pathological characteristics. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.01.005","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mds.22096","volume":"24","author":"JP Covy","year":"2009","unstructured":"Covy JP, Yuan W, Waxman EA et al (2009) Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations. Mov Disord 24:32\u201339. https:\/\/doi.org\/10.1002\/mds.22096","journal-title":"Mov Disord"},{"key":"3088_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/pn-2023-003988","volume":"24","author":"PW Cullinane","year":"2024","unstructured":"Cullinane PW, Wrigley S, Bezerra Parmera J et al (2024) Pathology of neurodegenerative disease for the general neurologist. Pract Neurol 24:188. https:\/\/doi.org\/10.1136\/pn-2023-003988","journal-title":"Pract Neurol"},{"key":"3088_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157. https:\/\/doi.org\/10.1016\/S1474-4422(09)70238-8","journal-title":"Lancet Neurol"},{"key":"3088_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.172","author":"KM Doherty","year":"2013","unstructured":"Doherty KM, Silveira-Moriyama L, Parkkinen L et al (2013) Parkin disease: a clinicopathologic entity? JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2013.172","journal-title":"JAMA Neurol"},{"key":"3088_CR17","volume-title":"Principles and practice of movement disorders","author":"S Fahn","year":"2011","unstructured":"Fahn S, Jankovic J (2011) Principles and practice of movement disorders. Elsevier Saunders, New York"},{"key":"3088_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10846","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L et al (2004) Comparison of kindreds with Parkinsonism and \u03b1-Synuclein genomic multiplications. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"3088_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2008.08.004","author":"MJ Farrer","year":"2009","unstructured":"Farrer MJ, Williams LN, Algom AA et al (2009) Glucosidase-beta variations and Lewy body disorders. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.08.004","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR20","doi-asserted-by":"publisher","unstructured":"Farrer M, Chan P, Chen R, et al (2001) Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 50:. https:\/\/doi.org\/10.1002\/ana.1132","DOI":"10.1002\/ana.1132"},{"key":"3088_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","volume":"289","author":"G F\u00e9nelon","year":"2010","unstructured":"F\u00e9nelon G, Alves G (2010) Epidemiology of psychosis in Parkinson\u2019s disease. J Neurol Sci 289:12\u201317. https:\/\/doi.org\/10.1016\/j.jns.2009.08.014","journal-title":"J Neurol Sci"},{"key":"3088_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH ffytche","year":"2017","unstructured":"ffytche DH, Creese B, Politis M et al (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81\u201395. https:\/\/doi.org\/10.1038\/nrneurol.2016.200","journal-title":"Nat Rev Neurol"},{"key":"3088_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Mart\u00ed MJ, Ezquerra M et al (2007) G2019S <em>LRRK2<\/em> mutation causing Parkinson\u2019s disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626. https:\/\/doi.org\/10.1136\/jnnp.2006.107904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3088_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.02.010","author":"C Gaig","year":"2008","unstructured":"Gaig C, Ezquerra M, Mart\u00ed MJ et al (2008) Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2008.02.010","journal-title":"J Neurol Sci"},{"key":"3088_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699","volume":"103","author":"J Gallagher","year":"2024","unstructured":"Gallagher J, Gochanour C, Caspell-Garcia C et al (2024) Long-term dementia risk in Parkinson disease. Neurology 103:e209699. https:\/\/doi.org\/10.1212\/WNL.0000000000209699","journal-title":"Neurology"},{"key":"3088_CR26","doi-asserted-by":"publisher","unstructured":"Gennaro P, I TK, Judith A-C, et al (2022) Trial of Prasinezumab in Early-Stage Parkinson\u2019s Disease. New England Journal of Medicine 387:421\u2013432. https:\/\/doi.org\/10.1056\/NEJMoa2202867","DOI":"10.1056\/NEJMoa2202867"},{"key":"3088_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20791","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM et al (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.20791","journal-title":"Ann Neurol"},{"key":"3088_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17830-1","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM, Gandhi S et al (2005) A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(05)17830-1","journal-title":"Lancet"},{"key":"3088_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21281","author":"MT Giordana","year":"2007","unstructured":"Giordana MT, D\u2019Agostino C, Albani G et al (2007) Neuropathology of Parkinson\u2019s disease associated with the LRRK2 Ile1371Val mutation. Mov Disord. https:\/\/doi.org\/10.1002\/mds.21281","journal-title":"Mov Disord"},{"key":"3088_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"3088_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000230215.41296.18","author":"O Goker-Alpan","year":"2006","unstructured":"Goker-Alpan O, Giasson BI, Eblan MJ et al (2006) Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000230215.41296.18","journal-title":"Neurology"},{"key":"3088_CR32","doi-asserted-by":"publisher","unstructured":"Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E (2010) Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders. Acta Neuropathol 120:. https:\/\/doi.org\/10.1007\/s00401-010-0741-7","DOI":"10.1007\/s00401-010-0741-7"},{"key":"3088_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.410270309","volume":"27","author":"LI Golbe","year":"1990","unstructured":"Golbe LI, Di Iorio G, Bonavita V et al (1990) A large kindred with autosomal dominant Parkinson\u2019s disease. Ann Neurol 27:276\u2013282. https:\/\/doi.org\/10.1002\/ana.410270309","journal-title":"Ann Neurol"},{"key":"3088_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-010-0669-y","volume":"120","author":"A Gomez","year":"2010","unstructured":"Gomez A, Ferrer I (2010) Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathol 120:155\u2013167. https:\/\/doi.org\/10.1007\/s00401-010-0669-y","journal-title":"Acta Neuropathol"},{"key":"3088_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(03)00016-6","author":"N Gouider-Khouja","year":"2003","unstructured":"Gouider-Khouja N, Larnaout A, Amouri R et al (2003) Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/S1353-8020(03)00016-6","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s004010051177","author":"K Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy K, Mehta ND, Farrer M et al (2000) Distinctive neuropathology revealed by \u03b1-synuclein antibodies in hereditary parkonsonism and dementia linked to chromosome 4p. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s004010051177","journal-title":"Acta Neuropathol"},{"key":"3088_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2008.07.010","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa K, Stoessl AJ, Yokoyama T et al (2009) Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.07.010","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR38","doi-asserted-by":"crossref","unstructured":"Hayashi S, Wakabayashi K, Ishikawa A, et al (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15:884\u2013888.","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8"},{"key":"3088_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mds.20324","volume":"20","author":"MA Hely","year":"2005","unstructured":"Hely MA, Morris JGL, Reid WGJ, Trafficante R (2005) Sydney multicenter study of Parkinson\u2019s disease: non-L-dopa\u2013responsive problems dominate at 15 years. Mov Disord 20:190\u2013199. https:\/\/doi.org\/10.1002\/mds.20324","journal-title":"Mov Disord"},{"key":"3088_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY (2019) Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun 7:183. https:\/\/doi.org\/10.1186\/s40478-019-0836-x","journal-title":"Acta Neuropathol Commun"},{"key":"3088_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"3088_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","volume":"124","author":"H Houlden","year":"2012","unstructured":"Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson\u2019s disease. Acta Neuropathol 124:325\u2013338. https:\/\/doi.org\/10.1007\/s00401-012-1013-5","journal-title":"Acta Neuropathol"},{"key":"3088_CR43","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddz241","volume":"28","author":"A Ikeda","year":"2019","unstructured":"Ikeda A, Nishioka K, Meng H et al (2019) Mutations in CHCHD2 cause \u03b1-synuclein aggregation. Hum Mol Genet 28:3895\u20133911. https:\/\/doi.org\/10.1093\/hmg\/ddz241","journal-title":"Hum Mol Genet"},{"key":"3088_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.4.514","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A et al (2008) Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.65.4.514","journal-title":"Arch Neurol"},{"key":"3088_CR45","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci 14:626\u2013636. https:\/\/doi.org\/10.1038\/nrn3549","journal-title":"Nat Rev Neurosci"},{"key":"3088_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/mdc3.14068","volume":"11","author":"LM Jackson","year":"2024","unstructured":"Jackson LM, Woodruff BK, Tremblay C et al (2024) Parkinson\u2019s disease associated with G2019S LRRK2 mutations without Lewy body pathology. Mov Disord Clin Pract 11:874\u2013878. https:\/\/doi.org\/10.1002\/mdc3.14068","journal-title":"Mov Disord Clin Pract"},{"key":"3088_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-025-02871-w","author":"NM Jensen","year":"2025","unstructured":"Jensen NM, Vitic Z, Antorini MR et al (2025) Abundant non-inclusion \u03b1-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-025-02871-w","journal-title":"Acta Neuropathol"},{"key":"3088_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6838965","author":"KK Johansen","year":"2018","unstructured":"Johansen KK, Torp SH, Farrer MJ et al (2018) A case of Parkinson\u2019s disease with no Lewy body pathology due to a homozygous exon deletion in Parkin. Case Rep Neurol Med. https:\/\/doi.org\/10.1155\/2018\/6838965","journal-title":"Case Rep Neurol Med"},{"key":"3088_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati L-N et al (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2704","journal-title":"JAMA Neurol"},{"key":"3088_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.994","author":"E Kara","year":"2014","unstructured":"Kara E, Kiely AP, Proukakis C et al (2014) A 6.4 Mb duplication of the \u03b1-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2014.994","journal-title":"JAMA Neurol"},{"key":"3088_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J et al (2018) Genotype-phenotype relations for the Parkinson\u2019s disease genes Parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord 33:730\u2013741. https:\/\/doi.org\/10.1002\/mds.27352","journal-title":"Mov Disord"},{"key":"3088_CR52","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/awg142","volume":"126","author":"NL Khan","year":"2003","unstructured":"Khan NL, Graham E, Critchley P et al (2003) Parkin disease: a phenotypic study of a large case series. Brain 126:1279\u20131292. https:\/\/doi.org\/10.1093\/brain\/awg142","journal-title":"Brain"},{"key":"3088_CR53","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1093\/brain\/awh667","volume":"128","author":"NL Khan","year":"2005","unstructured":"Khan NL, Jain S, Lynch JM et al (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson\u2019s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128:2786\u20132796. https:\/\/doi.org\/10.1093\/brain\/awh667","journal-title":"Brain"},{"key":"3088_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1096-7","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E et al (2013) A-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-013-1096-7","journal-title":"Acta Neuropathol"},{"key":"3088_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0038-3","volume":"10","author":"AP Kiely","year":"2015","unstructured":"Kiely AP, Ling H, Asi YT et al (2015) Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener 10:41. https:\/\/doi.org\/10.1186\/s13024-015-0038-3","journal-title":"Mol Neurodegener"},{"key":"3088_CR56","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awae073","volume":"147","author":"MJ Kmiecik","year":"2024","unstructured":"Kmiecik MJ, Micheletti S, Coker D et al (2024) Genetic analysis and natural history of Parkinson\u2019s disease due to the LRRK2 G2019S variant. Brain 147:1996\u20132008. https:\/\/doi.org\/10.1093\/brain\/awae073","journal-title":"Brain"},{"key":"3088_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.09.007","author":"T Konno","year":"2016","unstructured":"Konno T, Ross OA, Puschmann A et al (2016) Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.007","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR58","doi-asserted-by":"publisher","unstructured":"Kotzbauer PT, Giasson BI, Kravitz A V., et al (2004) Fibrillization of \u03b1-synuclein and tau in familial Parkinson\u2019s disease caused by the A53T \u03b1-synuclein mutation. Exp Neurol 187:. https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.007","DOI":"10.1016\/j.expneurol.2004.01.007"},{"key":"3088_CR59","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA et al (2022) Trial of Cinpanemab in early Parkinson\u2019s disease. N Engl J Med 387:408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"},{"key":"3088_CR60","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F et al (2013) G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome. Ann Neurol 73:459\u2013471. https:\/\/doi.org\/10.1002\/ana.23894","journal-title":"Ann Neurol"},{"key":"3088_CR61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","volume":"98","author":"S Lesage","year":"2016","unstructured":"Lesage S, Drouet V, Majounie E et al (2016) Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/Parkin-dependent mitophagy. Am J Hum Genet 98:500\u2013513. https:\/\/doi.org\/10.1016\/j.ajhg.2016.01.014","journal-title":"Am J Hum Genet"},{"key":"3088_CR200","doi-asserted-by":"publisher","unstructured":"Lim S-Y, Klein C (2024) Parkinson\u2019s disease is predominantly a genetic disease. J Parkinsons Dis 14(3):467\u2013482. https:\/\/doi.org\/10.3233\/JPD-230376","DOI":"10.3233\/JPD-230376"},{"key":"3088_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2003.11.004","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O et al (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab. https:\/\/doi.org\/10.1016\/j.ymgme.2003.11.004","journal-title":"Mol Genet Metab"},{"key":"3088_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2019.05.022","volume":"65","author":"N Malek","year":"2019","unstructured":"Malek N, Kanavou S, Lawton MA et al (2019) L-dopa responsiveness in early Parkinson\u2019s disease is associated with the rate of motor progression. Parkinsonism Relat Disord 65:55\u201361. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.022","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou K, Dickson DW, McComb RD et al (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Acta Neuropathol 116:25\u201335. https:\/\/doi.org\/10.1007\/s00401-008-0372-4","journal-title":"Acta Neuropathol"},{"key":"3088_CR65","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/mds.22677","volume":"24","author":"J-F Mart\u00ed-Mass\u00f3","year":"2009","unstructured":"Mart\u00ed-Mass\u00f3 J-F, Ruiz-Mart\u00ednez J, Bola\u00f1o MJ et al (2009) Neuropathology of Parkinson\u2019s disease with the R1441G mutation in LRRK2. Mov Disord 24:1998\u20132001. https:\/\/doi.org\/10.1002\/mds.22677","journal-title":"Mov Disord"},{"key":"3088_CR66","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.68","author":"IF Mata","year":"2008","unstructured":"Mata IF, Samii A, Schneer SH et al (2008) Glucocerebrosidase gene mutations: A risk factor for Lewy body disorders. Arch Neurol. https:\/\/doi.org\/10.1001\/archneurol.2007.68","journal-title":"Arch Neurol"},{"key":"3088_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25346","author":"S Miyakawa","year":"2013","unstructured":"Miyakawa S, Ogino M, Funabe S et al (2013) Lewy body pathology in a patient with a homozygous Parkin deletion. Mov Disord. https:\/\/doi.org\/10.1002\/mds.25346","journal-title":"Mov Disord"},{"key":"3088_CR68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.3.890","author":"H Mori","year":"1998","unstructured":"Mori H, Kondo T, Yokochi M et al (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology. https:\/\/doi.org\/10.1212\/WNL.51.3.890","journal-title":"Neurology"},{"key":"3088_CR69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"3088_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430612","author":"MD Muenter","year":"1998","unstructured":"Muenter MD, Forno LS, Hornykiewicz O et al (1998) Hereditary form of parkinsonism-dementia. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.410430612","journal-title":"Ann Neurol"},{"key":"3088_CR71","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/10790268.2018.1557863","volume":"43","author":"R Nardone","year":"2020","unstructured":"Nardone R, H\u00f6ller Y, Brigo F et al (2020) Spinal cord involvement in Lewy body-related \u03b1-synucleinopathies. J Spinal Cord Med 43:832\u2013845. https:\/\/doi.org\/10.1080\/10790268.2018.1557863","journal-title":"J Spinal Cord Med"},{"key":"3088_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp044","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E et al (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awp044","journal-title":"Brain"},{"key":"3088_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.parkreldis.2020.11.001","volume":"81","author":"K Nishioka","year":"2020","unstructured":"Nishioka K, Hashizume Y, Takanashi M et al (2020) Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson\u2019s disease. Parkinsonism Relat Disord 81:183\u2013187. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.001","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR74","doi-asserted-by":"publisher","unstructured":"Nishioka K, Ross OA, Vilari\u00f1o-G\u00fcell C, et al (2011) Glucocerebrosidase mutations in diffuse Lewy body disease. Parkinsonism Relat Disord 17:. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.09.009","DOI":"10.1016\/j.parkreldis.2010.09.009"},{"key":"3088_CR75","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.07.023","volume":"78","author":"CJ Nyb\u00f8","year":"2020","unstructured":"Nyb\u00f8 CJ, Gustavsson EK, Farrer MJ, Aasly JO (2020) Neuropathological findings in PINK1-associated Parkinson\u2019s disease. Parkinsonism Relat Disord 78:105\u2013108. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.07.023","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR76","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000299387.59159.db","author":"T Obi","year":"2008","unstructured":"Obi T, Nishioka K, Ross OA et al (2008) Clinicopathologic study of a SNCA gene duplication patient with parkinson disease and dementia. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000299387.59159.db","journal-title":"Neurology"},{"key":"3088_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20594","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Yokochi M et al (2005) Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord. https:\/\/doi.org\/10.1002\/mds.20594","journal-title":"Mov Disord"},{"key":"3088_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107826","author":"JB Parmera","year":"2025","unstructured":"Parmera JB, Wrigley S, Cullinane PW et al (2025) The impact of cognitive impairment and Alzheimer\u2019s disease neuropathological changes on gait, freezing and falls in Parkinson\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107826","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR79","doi-asserted-by":"publisher","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen P, Myllykangas L, Siitonen M et al (2014) A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35:2180.e1-2180.e5. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.024","journal-title":"Neurobiol Aging"},{"key":"3088_CR80","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou M, Dwamena BA, Foerster BR et al (2015) Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov Disord 30:928\u2013935. https:\/\/doi.org\/10.1002\/mds.26191","journal-title":"Mov Disord"},{"key":"3088_CR81","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"3088_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12031-011-9696-y","volume":"47","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Cortes E, Vonsattel J-PG et al (2012a) Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J Mol Neurosci 47:139\u2013143. https:\/\/doi.org\/10.1007\/s12031-011-9696-y","journal-title":"J Mol Neurosci"},{"key":"3088_CR83","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Levy OA, Alcalay RN (2012b) The neuropathology of genetic Parkinson\u2019s disease. Mov Disord 27:831\u2013842. https:\/\/doi.org\/10.1002\/mds.24962","journal-title":"Mov Disord"},{"key":"3088_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20587","author":"PP Pramstaller","year":"2005","unstructured":"Pramstaller PP, Schlossmacher MG, Jacques TS et al (2005) Lewy body Parkinson\u2019s disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.20587","journal-title":"Ann Neurol"},{"key":"3088_CR85","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Dudzik CG, Brier T et al (2013) A novel \u03b1-synuclein missense mutation in Parkinson disease. Neurology 80:1062","journal-title":"Neurology"},{"key":"3088_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.11.019","author":"A Puschmann","year":"2012","unstructured":"Puschmann A, Englund E, Ross OA et al (2012) First neuropathological description of a patient with Parkinson\u2019s disease and LRRK2 p.N1437H mutation. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.11.019","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR87","doi-asserted-by":"publisher","unstructured":"Rajput A, Dickson DW, Robinson CA, et al (2006) Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67:. https:\/\/doi.org\/10.1212\/01.wnl.0000240220.33950.0c","DOI":"10.1212\/01.wnl.0000240220.33950.0c"},{"key":"3088_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20731","author":"OA Ross","year":"2006","unstructured":"Ross OA, Toft M, Whittle AJ et al (2006) Lrrk2 and Lewy body disease. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.20731","journal-title":"Ann Neurol"},{"key":"3088_CR89","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-012-0991-7","volume":"123","author":"C Ruffmann","year":"2012","unstructured":"Ruffmann C, Zini M, Goldwurm S et al (2012) Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2). Acta Neuropathol 123:901\u2013903. https:\/\/doi.org\/10.1007\/s00401-012-0991-7","journal-title":"Acta Neuropathol"},{"key":"3088_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2021.09.009","volume":"91","author":"M Sakuwa","year":"2021","unstructured":"Sakuwa M, Adachi T, Suzuki Y et al (2021) First Japanese autopsy case showing LRRK2 mutation G2019S and TDP-43 proteinopathy. Parkinsonism Relat Disord 91:85\u201387. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.009","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR91","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awq051","volume":"133","author":"L Samaranch","year":"2010","unstructured":"Samaranch L, Lorenzo-Betancor O, Arbelo JM et al (2010) PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 133:1128\u20131142. https:\/\/doi.org\/10.1093\/brain\/awq051","journal-title":"Brain"},{"key":"3088_CR92","doi-asserted-by":"publisher","unstructured":"Sasaki S, Shirata A, Yamane K, Iwata M (2004) Parkin-positive autosomal recessive juvenile parkinsonism with \u03b1-synuclein-positive inclusions. Neurology 63:. https:\/\/doi.org\/10.1212\/01.WNL.0000134657.25904.0B","DOI":"10.1212\/01.WNL.0000134657.25904.0B"},{"key":"3088_CR93","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523. https:\/\/doi.org\/10.1002\/mds.27193","journal-title":"Mov Disord"},{"key":"3088_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21966","author":"K Seidel","year":"2010","unstructured":"Seidel K, Sch\u00f6ls L, Nuber S et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.21966","journal-title":"Ann Neurol"},{"key":"3088_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28521","author":"N Seike","year":"2021","unstructured":"Seike N, Yokoseki A, Takeuchi R et al (2021) Genetic variations and neuropathologic features of patients with PRKN mutations. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28521","journal-title":"Mov Disord"},{"key":"3088_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-025-02872-9","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Hashimoto Y et al (2025) Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-025-02872-9","journal-title":"Acta Neuropathol"},{"key":"3088_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120077","author":"C Severiano e Sousa","year":"2022","unstructured":"Severiano e Sousa C, Alarc\u00e3o J, Pav\u00e3o Martins I, Ferreira JJ (2022) Frequency of dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2021.120077","journal-title":"J Neurol Sci"},{"key":"3088_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25792","author":"ME Sharp","year":"2014","unstructured":"Sharp ME, Marder KS, C\u00f4t\u00e9 L et al (2014) Parkinson\u2019s disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Mov Disord. https:\/\/doi.org\/10.1002\/mds.25792","journal-title":"Mov Disord"},{"key":"3088_CR100","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant D-E et al (2023) <article-title update=\"added\">Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"key":"3088_CR101","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000326575.20829.45","author":"L Silveira-Moriyama","year":"2008","unstructured":"Silveira-Moriyama L, Guedes LC, Kingsbury A et al (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000326575.20829.45","journal-title":"Neurology"},{"key":"3088_CR102","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K et al (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"key":"3088_CR103","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K et al (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3088_CR104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-021-01121-w","volume":"9","author":"S Smolders","year":"2021","unstructured":"Smolders S, Philtjens S, Crosiers D et al (2021) Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson\u2019s disease. Acta Neuropathol Commun 9:25. https:\/\/doi.org\/10.1186\/s40478-021-01121-w","journal-title":"Acta Neuropathol Commun"},{"key":"3088_CR105","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.67","volume":"49","author":"PJ Spira","year":"2001","unstructured":"Spira PJ, Sharpe DM, Halliday G et al (2001) Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation. Ann Neurol 49:313\u2013319. https:\/\/doi.org\/10.1002\/ana.67","journal-title":"Ann Neurol"},{"key":"3088_CR106","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.24346","volume":"77","author":"JC Steele","year":"2015","unstructured":"Steele JC, Guella I, Szu-Tu C et al (2015) Defining neurodegeneration on Guam by targeted genomic sequencing. Ann Neurol 77:458\u2013468. https:\/\/doi.org\/10.1002\/ana.24346","journal-title":"Ann Neurol"},{"key":"3088_CR107","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/brain\/aww080","volume":"139","author":"R Taipa","year":"2016","unstructured":"Taipa R, Pereira C, Reis I et al (2016) DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain 139:1680\u20131687. https:\/\/doi.org\/10.1093\/brain\/aww080","journal-title":"Brain"},{"key":"3088_CR108","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.44.3_part_1.437","author":"H Takahashi","year":"1994","unstructured":"Takahashi H, Ohama E, Suzuki S et al (1994) Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology. https:\/\/doi.org\/10.1212\/wnl.44.3_part_1.437","journal-title":"Neurology"},{"key":"3088_CR109","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1212\/WNL.0000000000002744","volume":"86","author":"M Takanashi","year":"2016","unstructured":"Takanashi M, Li Y, Hattori N (2016) Absence of Lewy pathology associated with PINK1 homozygous mutation. Neurology 86:2212\u20132213. https:\/\/doi.org\/10.1212\/WNL.0000000000002744","journal-title":"Neurology"},{"key":"3088_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0617-y","volume":"6","author":"M Takanashi","year":"2018","unstructured":"Takanashi M, Funayama M, Matsuura E et al (2018) Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun 6:105. https:\/\/doi.org\/10.1186\/s40478-018-0617-y","journal-title":"Acta Neuropathol Commun"},{"key":"3088_CR111","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.01.2011.3685","volume":"2011","author":"M Takao","year":"2011","unstructured":"Takao M, Aoyama M, Ishikawa K et al (2011) Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology. BMJ Case Rep 2011:bcr0120113685. https:\/\/doi.org\/10.1136\/bcr.01.2011.3685","journal-title":"BMJ Case Rep"},{"key":"3088_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(03)00071-4","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab. https:\/\/doi.org\/10.1016\/S1096-7192(03)00071-4","journal-title":"Mol Genet Metab"},{"key":"3088_CR113","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.555","author":"BPC Van De Warrenburg","year":"2001","unstructured":"Van De Warrenburg BPC, Lammens M, L\u00fccking CB et al (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology. https:\/\/doi.org\/10.1212\/WNL.56.4.555","journal-title":"Neurology"},{"key":"3088_CR114","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jnnp-2018-318473","volume":"90","author":"D Vilas","year":"2019","unstructured":"Vilas D, Gelpi E, Aldecoa I et al (2019) Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2 -associated Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 90:832\u2013833","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3088_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050883","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Hayashi S, Ishikawa A et al (1998) Autosomal dominant diffuse Lewy body disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s004010050883","journal-title":"Acta Neuropathol"},{"key":"3088_CR116","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JPD-230154","volume":"14","author":"L Walker","year":"2024","unstructured":"Walker L, Attems J (2024) Prevalence of concomitant pathologies in Parkinson\u2019s disease: implications for prognosis, diagnosis, and insights into common pathogenic mechanisms. J Parkinsons Dis 14:35\u201352. https:\/\/doi.org\/10.3233\/JPD-230154","journal-title":"J Parkinsons Dis"},{"key":"3088_CR117","doi-asserted-by":"publisher","unstructured":"Waters CH, Miller CA (1994) Autosomal dominant Lewy body parkinsonism in a four\u2010generation family. Ann Neurol 35:. https:\/\/doi.org\/10.1002\/ana.410350110","DOI":"10.1002\/ana.410350110"},{"key":"3088_CR118","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-005-1042-4","author":"K Yamaguchi","year":"2005","unstructured":"Yamaguchi K, Cochran EJ, Murrell JR et al (2005) Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the \u03b1-synuclein gene. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-005-1042-4","journal-title":"Acta Neuropathol"},{"key":"3088_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(98)00015-7","author":"Y Yamamura","year":"1998","unstructured":"Yamamura Y, Kuzuhara S, Kondo K et al (1998) Clinical, pathologic and genetic studies on autosomal recessive early- onset parkinsonism with diurnal fluctuation. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/S1353-8020(98)00015-7","journal-title":"Parkinsonism Relat Disord"},{"key":"3088_CR120","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5692\/clinicalneurol.50.156","volume":"50","author":"HS Yomono","year":"2010","unstructured":"Yomono HS, Kurisaki H, Hebisawa A et al (2010) An autopsy case of SCA2 with parkinsonian phenotype. Rinsho Shinkeigaku 50:156\u2013162. https:\/\/doi.org\/10.5692\/clinicalneurol.50.156","journal-title":"Rinsho Shinkeigaku"},{"key":"3088_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0054-4","volume":"4","author":"F Zafar","year":"2018","unstructured":"Zafar F, Valappil RA, Kim S et al (2018) Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson\u2019s disease. NPJ Parkinsons Dis 4:18. https:\/\/doi.org\/10.1038\/s41531-018-0054-4","journal-title":"NPJ Parkinsons Dis"},{"key":"3088_CR122","doi-asserted-by":"publisher","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, et al (2004) The New Mutation, E46K, of \u03b1-Synuclein Causes Parkinson and Lewy Body Dementia. Ann Neurol 55:. https:\/\/doi.org\/10.1002\/ana.10795","DOI":"10.1002\/ana.10795"},{"key":"3088_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134544","volume":"714","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen J, Xu C et al (2020) Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson\u2019s disease dementia: a meta-analysis. Neurosci Lett 714:134544. https:\/\/doi.org\/10.1016\/j.neulet.2019.134544","journal-title":"Neurosci Lett"},{"key":"3088_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2004.11.005","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"},{"key":"3088_CR125","doi-asserted-by":"publisher","unstructured":"Zimran A, Neudorfer O, Elstein D. (2005) The Glucocerebrosidase Gene and Parkinson\u2019s Disease in Ashkenazi Jews. New England Journal of Medicine 352:. https:\/\/doi.org\/10.1056\/nejm200502173520719","DOI":"10.1056\/nejm200502173520719"}],"updated-by":[{"DOI":"10.1007\/s00702-026-03136-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000}}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03088-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:06:54Z","timestamp":1785600414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03088-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":125,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3088"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03088-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Figure 2has been updated","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00702-026-03136-w","URL":"https:\/\/doi.org\/10.1007\/s00702-026-03136-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}